Literature DB >> 1912602

L-arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro.

A Mügge1, D G Harrison.   

Abstract

Bioassay studies suggest that impaired endothelium-dependent relaxation in atherosclerotic arteries is due to a reduced release of biologically active endothelium-derived relaxing factor (EDRF). We tested the hypothesis that endothelial dysfunction is caused by deficiency of the EDRF precursor L-arginine. Aortae from normal and cholesterol-fed (1%, 4 months) rabbits were excised and incubated for 1 h with 5 mM L-arginine. Pretreatment with L-arginine had no effect on the relaxation to acetylcholine in normal vessels and was without effect on the impaired response of atherosclerotic arteries to acetylcholine. This finding suggests that L-arginine deficiency is unlikely the underlying cause of impaired endothelium-dependent relaxation in the aorta of cholesterol-fed rabbits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912602     DOI: 10.1159/000158881

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  11 in total

1.  Abolition of flow-dependent EDRF release before that evoked by agonists in hypercholesterolaemic rabbits.

Authors:  I R Hutcheson; J A Smith; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 2.  Cellular and molecular mechanisms of endothelial cell dysfunction.

Authors:  D G Harrison
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  Insulin and the arginine paradox.

Authors:  S Kurz; D G Harrison
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

4.  Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells.

Authors:  Bernadette Chen; Krista Strauch; Yi Jin; Hongmei Cui; Leif D Nelin; Louis G Chicoine
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-07       Impact factor: 2.557

5.  Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.

Authors:  Chunying Li; Wei Huang; M Brennan Harris; Jonathan M Goolsby; Richard C Venema
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

6.  Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits.

Authors:  I Woditsch; K Schrör
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Authors:  J P Cooke; A H Singer; P Tsao; P Zera; R A Rowan; M E Billingham
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  L-Arginine does not improve endothelium-dependent relaxation inin vitro Watanabe rabbit thoracic aorta.

Authors:  L Caparrotta; L Pandolfo; A Chinellato; E Ragazzi; G Froldi; G Aliev; G Fassina
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

10.  Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability.

Authors:  J F Arnal; T Münzel; R C Venema; N L James; C L Bai; W E Mitch; D G Harrison
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.